Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Thomas Isiah III	2. Issuer Name and Ticker or Trading Symbol One World Pharma, Inc. [ OWPC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) CEO and Vice Chairman
(Last)          (First)          (Middle) 3471 WEST OQUENDO ROAD, SUITE 301	3. Date of Earliest Transaction (MM/DD/YYYY) 12/31/2020
(Street) LAS VEGAS, NV 89118 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to buy)	$0.55	12/31/2020		D			5500000	(1)	6/3/2030	Common Stock	5500000	$0	0	D
Stock Option (Right to buy)	$0.13	1/1/2021		A		5500000		(2)	12/31/2030	Common Stock	5500000	$0	5500000	D

Explanation of Responses:
(1)	The option vested as to 1,500,000 shares immediately upon issuance (June 3, 2020), as to 1,000,000 shares 120 days following the issuance date of the option (the "Second Vesting Date"), and as to the remaining 3,000,000 shares, quarterly over the three years following the Second Vesting Date.
(2)	The option vests as to 2,275,000 shares immediately, and as to the remaining 2,750,000 shares, in 11 installments of 250,000 shares each, on the 1st day of each of the next 11 calendar quarters, beginning April 1, 2021.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Thomas Isiah III 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS, NV 89118	X		CEO and Vice Chairman

Signatures
/s/ Isiah L. Thomas III		1/4/2021
**Signature of Reporting Person		Date